WILMINGTON, Mass., Jan. 13, 2015 /PRNewswire/ — Implant Sciences Corporation (IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today its QS-B220 explosives and drugs trace detector has received regulatory approval in Russia for transportation. This approval covers various forms of transportation in Russia, including aviation, rail, and subways. In addition, both the QS-B220 and QS-H150 have also received the Customs Union Declaration of Conformity certification. These approvals allow Implant Sciences to sell the units to customers in Russia, Belarus, and Kazakhstan for the next five years, subject to U.S. export approval.
“We are pleased to have received these approvals, particularly the transportation approval for the QS-B220, which is the Russian equivalent of the TSA in the United States,” stated Glenn D. Bolduc, President and CEO of Implant Sciences. “Although currently the U.S. government, through the Department of Commerce – Bureau of Industry and Security, has placed a hold on the issuance of new export licenses authorizing the export or re-export of items to Russia, this hold does not affect existing licenses issued by BIS. Implant Sciences currently holds export licenses for hundreds of systems to Russia, and we believe that these Russian approvals will have a long-term positive impact in terms of the opportunity in the Russian ETD market for our Company.”
Russia is the largest country in the world by territory, with the railway system being its key mode of transportation. With an operational length of over 85 thousand kilometers as at the end of 2013, it is the third largest rail network in the world in terms of track length. Furthermore, it is estimated that the Moscow Metro will spend $116 million on security for the passenger screening.
About the QS-B220 Desktop Explosives and Drugs Trace Detector
The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives as well as illicit drugs. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.
